Viewing Study NCT06216392


Ignite Creation Date: 2025-12-24 @ 3:22 PM
Ignite Modification Date: 2025-12-26 @ 2:12 AM
Study NCT ID: NCT06216392
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-01-22
First Post: 2024-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis
Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module